Auristatin F CAS:163768-50-1, a potent cytotoxic agent derived , demonstrates exceptional microtubule-disrupting properties. Its unique dolastatin 10 core with N-terminal maleimido functional group facilitates targeted conjugation, enabling the development of antibody-drug conjugates (ADCs). Auristatin F’s application in pharmaceutical research focuses on advancing targeted cancer therapies, harnessing its powerful cytotoxicity to improve the efficacy and specificity of oncological treatments.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.